10 cell and gene therapy manufacturing experts

Experience: Head Manufacturing, Science and Technology, Cell and Gene Therapies · Novartis

Former Head Manufacturing, Science and Technology, Cell and Gene Therapies at Novartis (2022–2025); the profile cites core competencies in manufacturing process improvement, process development and life cycle management for complex and novel products. His other Novartis roles include Global Product Lead (Cell&Gene) (2019–2022) and, since 2025, Director - TRD Project and Portfolio Management (TPPM).

Experience: Sr Director Cell Therapy Manufacturing · Genentech

Sr Director Cell Therapy Manufacturing at Genentech since July 2025. At Poseida Therapeutics, Inc. he was Executive Director Cell Therapy Manufacturing (2022–2025) and Sr Director Manufacturing (2019–2022), and at Atara Biotherapeutics he was Associate Director (2017–2019) and CMC Technical Manager (2015–2017).

Experience: Vice President, Head of Manufacturing · Vor Bio

Vice President, Head of Manufacturing at Vor Bio since April 2024; the profile describes international operations experience specializing in autologous cell therapies and virus manufacturing, with CRO/CMO/CTO oversight among his listed skills. He was Head Of Manufacturing at ONK Therapeutics (2022–2023) and Head of Manufacturing and Supply Chain at Minovia Therapeutics (2020–2022).

Experience: Director, Cell Therapy Manufacturing · AstraZeneca

Director, Cell Therapy Manufacturing at AstraZeneca since April 2026, with a profile headline citing cGMP operations for autologous and allogeneic therapies and manufacturing scale-up. He was Director Of Manufacturing at Sonoma Biotherapeutics, Inc. (2022–2026), Sr. Manager, CAR-T Manufacturing Operations at Bristol Myers Squibb (2019–2021) and Manager, CAR-T Manufacturing Operations at Juno Therapeutics, Inc. (2018–2019).

Experience: Head of Cell Therapy Manufacturing · AstraZeneca

Head of Cell Therapy Manufacturing at AstraZeneca since June 2024. She was also Vice President, Head of Manufacturing and Facilities (2023–2025) and Executive Director, Head of Manufacturing and Facilities (2021–2023) at Neogene Therapeutics, and Sr. Director Facilities and Engineering at Kite Pharma (2020–2021); the profile cites an emphasis on downstream purification processes and aseptic manufacturing.

Experience: Director, CAR T Manufacturing Operations · Bristol Myers Squibb

Director, CAR T Manufacturing Operations at Bristol Myers Squibb since July 2025, after serving there as Associate Director, CAR T Manufacturing Operations (2022–2025) and Senior Manager, CAR-T Manufacturing Operations (2020–2022). He was also Viral Vector Manufacturing Manager at Advanced Therapies, LLC (2018–2020) and Process Engineer at Bristol Myers Squibb (2015–2018).

Experience: Head of GMP CAR T Production · NHS

Head of GMP CAR T Production at NHS since November 2020, where the profile says she leads CAR T GMP production and process development for UCL trials and set up a manufacturing platform at the Centre for Cell, Gene and Tissue Therapeutics for production of GMP CAR T cells. She was Research Associate - Pule Translation Team at UCL (2017–2020).

Experience: Senior Director, Value Stream CAR-T Manufacturing Operations · Bristol Myers Squibb

Senior Director, Value Stream CAR-T Manufacturing Operations at Bristol Myers Squibb since 2023, with a profile headline citing CAR-T cell therapy manufacturing operations. At Sanofi she was Director - Aseptic Processing SME (2020–2023), Associate Director - Manufacturing (2017–2020) and Senior Manager - Manufacturing (2007–2020).

Experience: Senior Director and Head of MSAT, Rockville Manufacturing Center · AstraZeneca

Senior Director and Head of MSAT, Rockville Manufacturing Center at AstraZeneca since June 2024, where the profile describes leading operations at the GMP cell therapy site in Rockville and building MS&T capabilities for autologous CAR-T manufacturing and release. Other roles include Vice President (VP), Head of CMC and Tech Ops at NeuExcell Therapeutics (2022–2024) and Executive Director at Passage Bio (2020–2022).

Experience: Director of Manufacturing · AbelZeta

Director of Manufacturing at AbelZeta since October 2025, where the profile says he leads cGMP manufacturing operations for clinical-stage cell therapy products. At AbelZeta he was also US Supply Chain Head (2024–2025), leading the supply chain organization, and Director of Technical Operations (2023–2024).